portal vein造句
31. Objective To measure the data of the left stem and the right stem of hepatic portal vein after entering into liver and supply morphological data for interventional therapy for hepatopathy.
32. Objective: To determine the application of Color Doppler ultrasound in portal vein thrombopoiesis (PVT) after splenectomy .
33. Objective:To introduce a new therapy combining percutaneous laser and photosensitizer in treatment of portal vein tumor thrombus(PVTT), and evaluate the efficacy and validity of the method.
34. A conclusion could be drawn that NCE-MRA is a non-invasive and effective method that provides a comprehensive assessment of the hepatic portal vein.
35. Of or relating to the portal vein or the portal system.
36. Conclusion: The width of lingual vein is closely correlated with the diameters of portal vein and splenic vein in patients with primary liver cancer.
37. Objective : To explore the method and skill of laparoscopic portal vein intubation and embedding subcutaneous pump.
38. Objective To investigate the long-term effects of portal vein hemodynamic changes on liver function after portal vein arterialization(PVA) in rats.
39. The liver receives blood through two vascular systems, the portal vein and hepatic artery.
40. Methods Experimental model of partial portal vein arterialization was established in rats. The changes of hepatic microvasculature and histology in the rat model were observed.
41. Villa said that portal vein thrombosis is a clinically important complication of liver disease, occurring in 38% of patients within 18 months of diagnosis.
42. Results The main portal vein appearance was accordant with 3D CE MRP and direct x-ray portography in all cases.
43. For example: scan time, scan speed, 3D image composition. Therefore, when we perform CTA, it is accurately distinguish between hepatic artery and hepatic portal vein by use the Hounsfied Unit scan.
44. MRI also suggested hepatic metastasis in 4 cases, portal vein invasion in 7 cases.
45. American HP5500 ultrasound instrument was used to determine the diameters and average velocities of portal vein and splenic vein.
46. Objective To investigate the relationship between the levels of platelets membrane glucoprotein CD62P with thrombosis of portal vein after devascularization operation.
47. Conclusions Partial portal vein arterialization has no early effect on hepatic microvasculature and histologic structure.
48. Objective To investigate the changes of hepatic portal vein blood flow(PBF) and oxygen metabolism during normothermic or hypothermic cardiopulmonary bypass(CPB).
49. Objective To explore long-term effects of flow-restricted portal vein arterialization on hepatic function and structure in a rat model.
50. The variations of the portal vein were observed after reconstructing 3 - dimentional portal vein and hepatic veins.
51. Background: Serum- ascitic albumin gradient (SAAG) is an indirect parameter reflecting the portal vein pressure.
52. Plasma levels of ET-1 and GLU were positively correlated with portal vein diameters, splenic vein diameters and splenic vein flows.
53. MAIN OUTCOME MEASURES: Occurrence of branches of hepatic portal vein; clearness and satiation of the vessel wall.
54. Conclusion:Portacaval bypass is essential to portal vein reconstruction, and the bypass does not affect the blood supply of portal vein after reconstruction.
55. Results: DST, DSSL and DSBM can induce the specific tolerance by the way of portal vein infusion.
56. The concentration time curve of OLANa 2 in rats fitted in a one compartment open model with first order absorption after oral administration and hepatic portal vein injection.
57. Widths of liver and portal vein diameters and portacaval space will directly or indirectly reflect diseases of liver and determination of normal sizes in children can supply information of diagnosis.
58. Methods: Serum NO, transverse diameter and blow flow of hepatic portal vein were detected in 35 cirrhotics and 25 normal controls by colorimetric and Color Dopper respectively.
59. Objective:To study the relationship between hepatic encephalopathy and blood flow direction of intra hepatic portal vein after transjugular intrahepatic portosystemic stent shunt (TIPSS).
60. Conclusion: Liver steatosis can result in narrow and irregular liver sinus and increase the portal vein pressure.
1234